TUSA, IGNAZIA
 Distribuzione geografica
Continente #
NA - Nord America 3.143
EU - Europa 2.796
AS - Asia 1.656
SA - Sud America 200
Continente sconosciuto - Info sul continente non disponibili 129
AF - Africa 39
OC - Oceania 14
Totale 7.977
Nazione #
US - Stati Uniti d'America 3.052
PL - Polonia 824
IT - Italia 686
RU - Federazione Russa 662
CN - Cina 473
SG - Singapore 424
HK - Hong Kong 220
BR - Brasile 159
VN - Vietnam 140
IE - Irlanda 137
KR - Corea 121
DE - Germania 93
SE - Svezia 92
FR - Francia 79
FI - Finlandia 66
GB - Regno Unito 65
BD - Bangladesh 64
IN - India 61
CA - Canada 56
NL - Olanda 37
JO - Giordania 35
ID - Indonesia 33
JP - Giappone 28
AR - Argentina 16
MX - Messico 15
AU - Australia 13
CH - Svizzera 11
IQ - Iraq 10
BE - Belgio 9
CI - Costa d'Avorio 8
PK - Pakistan 8
EC - Ecuador 7
MA - Marocco 7
CO - Colombia 6
ES - Italia 6
NG - Nigeria 6
PH - Filippine 6
TR - Turchia 6
AT - Austria 5
CR - Costa Rica 5
UA - Ucraina 5
ZA - Sudafrica 5
EG - Egitto 4
LT - Lituania 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
DO - Repubblica Dominicana 3
PE - Perù 3
TW - Taiwan 3
UZ - Uzbekistan 3
VE - Venezuela 3
BJ - Benin 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
PR - Porto Rico 2
PT - Portogallo 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
DZ - Algeria 1
IL - Israele 1
IM - Isola di Man 1
KW - Kuwait 1
LY - Libia 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 7.848
Città #
Warsaw 822
Santa Clara 716
Ashburn 436
Singapore 318
Hong Kong 191
Fairfield 180
Florence 158
Chandler 152
San Jose 133
Dublin 132
Seoul 119
Seattle 99
Hefei 94
Council Bluffs 90
Woodbridge 88
Milan 84
Beijing 77
Cambridge 75
Houston 69
Ann Arbor 65
Wilmington 61
Rome 50
Buffalo 48
Ho Chi Minh City 46
Munich 44
Lawrence 43
Altamura 42
Los Angeles 42
Lauterbourg 38
New York 32
Princeton 31
Boston 30
Moscow 30
Mumbai 29
Jakarta 26
Paris 25
Kent 23
Shanghai 23
Turin 22
Dallas 20
Hanoi 20
Helsinki 20
Tokyo 20
San Diego 19
São Paulo 18
Frankfurt am Main 17
Turku 17
Dong Ket 16
Lappeenranta 16
The Dalles 16
London 15
Melbourne 13
Ottawa 13
Portsmouth 13
Boardman 12
Guangzhou 12
Montreal 12
Figino 11
Atlanta 10
Naples 10
Toronto 10
Brussels 9
Abidjan 8
Bologna 8
Chicago 8
Clifton 8
Prato 8
Bengaluru 7
Hangzhou 7
Nuremberg 7
Shenzhen 7
Bari 6
Chennai 6
Medford 6
Mexico City 6
Miano 6
Phoenix 6
Bern 5
Brasília 5
Cagliari 5
Charlotte 5
Da Nang 5
Goiânia 5
Orem 5
Pune 5
Redondo Beach 5
Renton 5
San José 5
San Juan 5
Zurich 5
Abuja 4
Baghdad 4
Brooklyn 4
Catania 4
Denver 4
Galliate 4
Haiphong 4
Liverpool 4
Messina 4
Padua 4
Totale 5.331
Nome #
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. 363
ERK5 is activated by oncogenic BRAF and promotes melanoma growth 346
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. 344
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 343
Role of ERK5/BMK1 in the survival, proliferation and stemness of chronic myeloid leukemia cells in hypoxia 314
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 298
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 297
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. 274
Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy 259
Anti-β4 integrin autoantibodies in patients with mucous membrane pemphigoid: a retrospective analysis from a tertiary centre in Italy 257
Importin subunit beta‐1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferation 252
Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway 248
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 236
AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia 218
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential 215
Hepatocyte-specific deletion of HIF2α prevents NASH-related liver carcinogenesis by decreasing cancer cell proliferation 199
Inhibition of ERK5 elicits cellular senescence in melanoma via the cyclin-dependent kinase inhibitor p21 195
ERK5 mediates pro-tumorigenic phenotype in non-small lung cancer cells induced by PGE2 190
Altered fatty acid metabolism rewires cholangiocarcinoma stemness features 187
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 185
Playing the Whack-A-Mole Game: ERK5 Activation Emerges Among the Resistance Mechanisms to RAF-MEK1/2-ERK1/2- Targeted Therapy 184
Lactate maintainsBCR/Abl expression and signalinginChronic Myeloid Leukemia cells under nutrient restriction 182
The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells 172
Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress 171
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 167
ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL 161
Sphingosine 1-phosphate elicits a ROS-mediated proinflammatory response in human endometrial stromal cells via ERK5 activation 157
Non-thermal effects of 2.45 GHz microwaves on spindle assembly, mitotic cells and viability of Chinese hamster V-79 cells 157
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 150
ERK5-INHIBITION AS A NOVEL APPROACH TO TARGET CML STEM CELLS 150
Latent-transforming growth factor β-binding protein 1/Transforming growth factor β1 complex drives antitumoral effects upon ERK5 targeting in melanoma 145
ERK5 inhibition elicits cellular senescence in human melanoma cells 144
Ganglioside GD2 Contributes to a Stem-Like Phenotype in Intrahepatic Cholangiocarcinoma 136
The MEK5/ERK5 pathway promotes the activation of the Hedgehog/GLI signaling in melanoma cells 124
Spontaneous and bleomycin-induced chromosome damage in non cancer thyroid patients. 114
Liquid Crystalline Networks Hamper the Malignancy of Cancer Cells 102
Positive correlation of HIF2α and SERPINB3 in human hepatocellular carcinoma: selectivity and prognostic implications 97
Targeting MAPK in Cancer 2.0 94
Development of a chaperone-mediated protein degrader targeting ERK5 that efficaciously reduces tumor growth 68
The role of OSM/OSMRβ axis in shaping the tumor microenvironment favouring MASLD-Related HCC immune evasion 52
Dual-Specificity Protein Phosphatases Targeting Extracellular Signal-Regulated Kinases: Friends or Foes in the Biology of Cancer? 30
Totale 7.977
Categoria #
all - tutte 21.747
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.747


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022286 0 15 23 20 17 10 25 14 36 23 42 61
2022/2023676 52 117 44 28 53 110 88 56 90 9 13 16
2023/2024311 12 22 32 14 14 37 21 84 9 18 32 16
2024/20252.211 89 194 117 299 587 309 57 129 96 97 112 125
2025/20262.620 296 317 225 184 263 93 290 115 198 209 117 313
2026/2027170 132 38 0 0 0 0 0 0 0 0 0 0
Totale 7.977